[Very late drug-eluting stent thrombosis by stent fracture].
R Cheaito, A Tritar, A Scemama, W Ferrag, P Goy, F Haziza, H Benamer
Author Information
R Cheaito: Département de cardiologie interventionnelle, hôpital Foch, 40, rue Worth, 92151 Suresnes, France. Electronic address: cheaito_radi@hotmail.fr.
A Tritar: Département de cardiologie interventionnelle, hôpital Foch, 40, rue Worth, 92151 Suresnes, France.
A Scemama: Département de cardiologie interventionnelle, hôpital Foch, 40, rue Worth, 92151 Suresnes, France.
W Ferrag: Département de cardiologie interventionnelle, hôpital Foch, 40, rue Worth, 92151 Suresnes, France.
P Goy: Département de cardiologie interventionnelle, hôpital Foch, 40, rue Worth, 92151 Suresnes, France.
F Haziza: Département de cardiologie interventionnelle, hôpital Foch, 40, rue Worth, 92151 Suresnes, France.
H Benamer: Département de cardiologie interventionnelle, hôpital Foch, 40, rue Worth, 92151 Suresnes, France.
The superiority of drug-eluting stents in reducing the risk of in-stent restenosis compared to bare-metal stents is no longer challenged. Nevertheless, the drug-eluting stents may carry long-term risk of late and very late stent thrombosis. The promoting factors of this complication are usually divided into three chapters depending on the patient, the procedure and the stent. Indeed, the literature has reported several parameters related to the stent itself, such as its length, the malapposition, its diameter, but also more rarely the occurrence of stent fracture. We present the case of a patient admitted for myocardial infarction after a very late thrombosis of Cypher drug-eluting stent four years after its implantation and related to stent fracture.
